VALIDATION IMAGES
IF(ICC) staining with Apolipoprotein A2 (2H4) Monoclonal Antibody (bsm-54292R) at 1:200 in HepG2 cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
IF(ICC) staining with Apolipoprotein A2 (2H4) Monoclonal Antibody (bsm-54292R) at 1:200 in LOVO cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
IF(ICC) staining with Apolipoprotein A2 (2H4) Monoclonal Antibody (bsm-54292R) at 1:200 in SH-SY5Y cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
Paraformaldehyde-fixed and paraffin-embedded Rat Large Intestine tissue incubated with Apolipoprotein A2 (2H4) Monoclonal Antibody (bsm-54292R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Rat Liver tissue incubated with Apolipoprotein A2 (2H4) Monoclonal Antibody (bsm-54292R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human Liver tissue incubated with Apolipoprotein A2 (2H4) Monoclonal Antibody (bsm-54292R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Flow cytometric analysis of HepG2 cells with Apolipoprotein A2 (2H4) Monoclonal Antibody (bsm-54292R) at a 1:100 dilution (red) compared with an unlabeled control (cells without incubation with primary antibody; black).